Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Juni 2023

Genmab — Juni 2023

Planlagt Fastgjort Låst Flyttet Genmab
702 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • R Offline
    R Offline
    Riis7
    wrote on sidst redigeret af
    #654

    shorte

    1 Reply Last reply
    0
    • E Offline
      E Offline
      E_L
      wrote on sidst redigeret af
      #655

      @lahn1 JNJ opting in to Hexabody-CD38 would be by far the easiest and i imagine would get a very positive market reaction. It proofs JNJ believes in the product and they will take over all development and costs. But lately i have been wondering more and more if it could not be more profitable for Genmab to develop it themselves for the areas you mention...

      1 Reply Last reply
      0
      • E Offline
        E Offline
        E_L
        wrote on sidst redigeret af
        #656

        Definately more risky, more own investments, but in potentially very profitable areas of disease with full profit...

        1 Reply Last reply
        0
        • E Offline
          E Offline
          E_L
          wrote on sidst redigeret af
          #657

          But the choice is not in their hands anymore, it's all op to JNJ now

          1 Reply Last reply
          0
          • BulderB Offline
            BulderB Offline
            Bulder
            wrote on sidst redigeret af
            #658

            I think it’s a bit strange that genmab accepted these limitations should jnj choose not to opt in.

            1 Reply Last reply
            0
            • K Offline
              K Offline
              Klarussen
              wrote on sidst redigeret af
              #659

              Børsen: "Eli Lilly har indgået en aftale om at købe Sigilon Therapeutics, hvilket har fået aktien i sidstnævnte til at stige med 700 pct. i det amerikanske formarked." De skulle have budt på Genmab.

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #660

                That originated from the earlier agreement on daratumumab, where I assume Genmab agreed they would not be allowed to compete with dara in that space with another product...

                1 Reply Last reply
                0
                • E Offline
                  E Offline
                  E_L
                  wrote on sidst redigeret af
                  #661

                  There is good reason Jan only wants 50/50 deals going forward, they learned...

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #662

                    and to be honest, they had no choice at the time, circumstances where very different as you know , they had no negotiating power

                    1 Reply Last reply
                    0
                    • P Offline
                      P Offline
                      Pensionisten
                      wrote on sidst redigeret af
                      #663

                      @g

                      1 Reply Last reply
                      0
                      • P Offline
                        P Offline
                        Pensionisten
                        wrote on sidst redigeret af
                        #664

                        @gdn55 - et supplerende spørgsmål til dit indlæg 14:32: Hvor i mine indlæg ser du, at jeg forventer Genmab fortsat vil falde? Mig bekendt, har jeg kun kommenteret på den udvikling, der er sket 😉

                        1 Reply Last reply
                        0
                        • S Offline
                          S Offline
                          Sukkeralf
                          wrote on sidst redigeret af
                          #665

                          Lets not forget Janssen did a perfect job developing daratumumab fast and kicked both Sanofi and Morphosys drug candidates. Genmab picked the right partner for sure and we just need 5 more years income…….please

                          1 Reply Last reply
                          0
                          • P Offline
                            P Offline
                            Pensionisten
                            wrote on sidst redigeret af
                            #666

                            @Sukkeralf. Hvor har du ret - men det er jo trådt lid i baggrunden efter 2 tabte voldgifter 😉

                            1 Reply Last reply
                            0
                            • BulderB Offline
                              BulderB Offline
                              Bulder
                              wrote on sidst redigeret af
                              #667

                              Når der skal trækkes lod med 3 kugler i hatten, hvor de 2 er grønne, den ene rød, så er der størst sandsynlighed for at trække en grøn. De 2 grønne er vundet appel og hex38 ta’r kegler. Den røde er: Ingen af delene. 😉

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #668

                                I fully agree Sukkeralf, JNJ have done an amazing job and helped genmab survive. But they also did a great job making that deal at the time, with the leverage they had 😉 (and I can't blame them for that
                                )

                                1 Reply Last reply
                                0
                                • B Offline
                                  B Offline
                                  bikube
                                  wrote on sidst redigeret af
                                  #669

                                  Hov - Genmab blev grøn !!

                                  1 Reply Last reply
                                  0
                                  • G Offline
                                    G Offline
                                    gdn55
                                    wrote on sidst redigeret af
                                    #670

                                    Til Pensionisten. Det kan være jeg bare ikke har forstået din måde at udtrykke sig på. Jeg har desværre kun gået ni år i skole, så du må have mig undskyldt

                                    1 Reply Last reply
                                    0
                                    • P Offline
                                      P Offline
                                      Pensionisten
                                      wrote on sidst redigeret af
                                      #671

                                      Så er vi stort set ligestillede… jeg er årgang 53 😄

                                      1 Reply Last reply
                                      0
                                      • G Offline
                                        G Offline
                                        gdn55
                                        wrote on sidst redigeret af
                                        #672

                                        Jeg årgang 55

                                        1 Reply Last reply
                                        0
                                        • P Offline
                                          P Offline
                                          Pensionisten
                                          wrote on sidst redigeret af
                                          #673

                                          Så er du jo forholdsvis ung 😉

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper